PALANISAMY SIVANANDY

Designation/Title: Lecturer
Department: Department of Pharmacy Practice, School of Pharmacy
Tel: +6011-12327819
Fax: 
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

Education and Training

GCP

Good Clinical Practice, Ministry of Health, Malaysia

-
PhD TNMMU, Chennai, India -
M.Pharm. TNMMU, Chennai, India -
B.Pharm. TNMMU, Chennai, India -
D.Pharm. Directorate of Medical Education, Chennai, India -

 

Research interests:

  • Pharmacovigilance
  • Pharmacoeconomics
  • Drug utilization in metabolic disorders, Prescription auditing,
  • Patient compliance or Medication adherence
  • Cancer chemotherapy
  • Patient Safety

 

Research projects/grants:

International (as Principal Investigator): -

National Research & Development Grants:

  • A study on assessment, monitoring and documentation of adverse drug reactions in Indian hospital. Indian Council of Medical Research, (ICMR), USD 1610, 2011.
  • A prospective study on adverse drug reactions and signal detection. Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, USD 2407, 2013.

 

Supervision of Postgraduates (MSc/PhD)
(Last 5 years – 2010-2014)

  • Study on factors related to medication non-adherence and effect of pharmacist intervention to improve patient adherence with antihypertensive medications at a tertiary care teaching hospital.
  • Intervention to improve patient adherence with antihypertensive medications at a tertiary care teaching hospital.
  • A study on assessment, monitoring, documentation and reporting of adverse drug reactions at a multi-specialty tertiary care teaching hospital in South India. 2010-2012.
  • Safety and efficacy of thrombolytic therapy using rt-PA (Alteplase) in acute ischemic stroke. Binny T, 2011.
  • A study on assessment, monitoring and documentation of adverse drug reactions. Yamini P, 2012.
  • A study on utilization of erythropoietin in renal anemia. Tinu T, Veerendra C, 2012.

 

Professional affiliations:

  • Life member, State Pharmacy Council, Tamilnadu, India
  • Life member, Pharmacy Council of India
  • Life member, Association of Pharmaceutical Teachers of India
  • Member, International Society of Pharmacovigilance
  • Member, International Society of Pharmacoeconomics and Outcomes Research

 

Academic Awards: -

  • -

 

Recent publications
(last 5 years – 2010-2014)

2010

  • Arul Kumaran KSG, Chistopher Vimalson D, and Jagadeesan M, Palanisamy S. Evaluation of suspending properties of Cassia Roxburghii mucilage on sulphamethoxazole suspension. Int. J. Pharma and Bio Sci. 2010; 1(2): 1-10.
  • Arul Kumaran KSG, Palanisamy S, Rajasekaran A, and Ahil Hari. Evaluation of cassia roxburghii seed gum as binder in tablet formulations of selected drugs. Int. J. Pharm. Sci. Nanotech. 2010; 2(4): 726-732.
  • Arul Kumaran KSG, Palanisamy S, and Rajasekaran A. Development and implementation of patient information leaflets in diabetes mellitus. J. Pharm. Health Serv. Res. 2010; 1: 85-89.
  • Arul Kumaran KSG, Palanisamy S, and Jagadeesan M. Pharmacognostical studies on seeds of cassia roxburghii DC. Int. Res. J. Pharm. Sci. 2010; 1(1): 27-31.
  • Palanisamy S, Sumathy A, and Tharabai R. A study on prescribing pattern of antihypertensives at a tertiary care hospital. Int. J. Pharm. Sci. Res. 2010; 1(8): 43-50.
  • Arul Kumaran KSG, Palanisamy S, Rajasekaran A, Jagadeesan M, and Kasyap PS. Use of natural gums and hydroxypropyl mehyl cellulose in formulations of sustained release matrix tablets of tramadol hydrochloride. J. Pharm. Tech. Res. 2010; 2(1): 48-54.

2011

  • Arul Kumaran KSG, Palanisamy S, and Sreekanth J. Formulation development and evaluation of Levodopa- Carbidopa orally disintegration tablets. J. Chem. Pharm. Res. 2011; 3(3): 169-175.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A study on adverse drug reactions in Indian hospital. Imperial J. Pharmacol. Toxicol. 2011; 1(1): 7-15.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A study on assessment, monitoring and reporting of adverse drug reactions in Indian hospital. Asian J. Pharm. Clin. Res. 2011; 4(3): 112-116. (Impact Factor: 0.32)
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A study on adverse drug reactions at a tertiary care teaching hospital. Int. J. Pharm. Teach. Pract. 2011; 2(3): 96-101.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A study on assessment, monitoring and reporting of adverse drug reactions in an Indian hospital. Drug Saf. 2011; 34(10): 948. (Impact Factor: 3.599)
  • Palanisamy S, Binny T, Vijayan K, and Sumathy A. Safety and efficacy of thrombolytic therapy using rt-PA (Alteplase) in acute ischemic stroke. ISRN Neurol. 2011; Article ID 618624, 6 pages, doi:10.5402/2011/618624

2012

  • Palanisamy S, and Yamini P. A study on assessment, monitoring and documentation of adverse drug reactions. Int. J. Pharm. Teach. Pract. 2012; 3(2): 253-256.
  • Palanisamy S, and Sumathy A. Prescribing pattern of drugs in children at a South Indian hospital. J. curr. Res. Ayur. Pharm. Sci. 2012; 3(6): 16-22.
  • Palanisamy S, Loganathan S, and Sumathy A. Prescribing pattern of drugs in paediatric inpatients. Int. J. Pharm. Sci. Rev. Res. 2012; 15(2): 16-19. (Impact Factor: 1.615)
  • Palanisamy S, Tinu T, Veerendra C, and Sumathy A. A study on utilization of erythropoietin in renal anemia. Biomirror. 2012; 3(12): 5-9.
  • Palanisamy S. A prospective study on adverse drug reactions in an Indian hospital. Clin. Exp. Pharmacol. 2012; 2(3): 70.

2013

  • Palanisamy S, Lakshmi SN, Shahid H, Sivakumar GM and Sumathy A. Management of pain in cancer patients at a south Indian hospital. J. App. Pharm. Sci. 2013; 3(1): 117-121.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A study on assessment of knowledge about adverse drug reactions. Der Pharmacia Lettre. 2013; 5(1): 41-52.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A prospective study on adverse drug reactions in an Indian hospital. J. Pharm. Nutri. Sci. 2013; 3(2): 149-162.
  • Palanisamy S, and Sumathy A. A prospective study on drug - drug interactions at a corporate hospital in Tamilnadu. Int. J. Pharmaceu. Res. 2013; 5(2): 52-56.
  • Karthik D, Palanisamy S, and Sumathy A. Dipeptidylpeptidase-4 inhibitory activity of Pergularia Daemia (Forsk) – an in-vitro estimation. Asian J. Research Chem. 2013; 6(6): 570-571.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A prospective study on adverse drug reactions in a tertiary care South Indian hospital. Indian J. Pharm. Pract. 2013; 6(2): 49-60.
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. Knowledge assessment in adverse drug reactions and reporting. Arch. Pharma. Pract. 2013; 4(3): 104-19.
  • Sumathy A, Palanisamy S, and Karthik D. A study on synthesis, molecular properties and antimicrobial activity of some quinazoline derivatives. J. Chem. Pharm. Res. 2013; 5(10): 1-9
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A prospective study on adverse drug reactions and signal detection. Open Access Scientific Reports. 2013; 2(4): 1-10. (Scientific reports- 750)
  • Palanisamy S, Arul Kumaran KSG, and Rajasekaran A. A prospective study on adverse drug reactions and signal detection. J.Pharmacovigilance. 2013; 1(4): 37.
  • Karthik D, Palanisamy S, and Sumathy A. Molecular docking studies and in-vitro acetylcholinesterase inhibition by terpenoids and flavonoids. Asian J. Research Chem. 2013; 6(11): 1011-1017.

2014

  • Karthik D, Palanisamy S, and Sumathy A. Molecular docking studies of anthraquinone derivatives on the crystal structure of glycogen synthase kinase 3 beta. Electronic Journal of Biology. 2014; 10(1): 14-20.
  • Karthik D, Palanisamy S, Sumathy A, and Khairunnisa K. A computational study on binding affinity of Bio-flavonoids on the crystal structure of 3-hydroxy-3-methyl-glutaryl-CoA reductase – An insilico molecular docking approach. Der Pharma Chemica, 2014; 6(2): 378-387.
  • Karthik D, Palanisamy S, Sumathy A, and Manojkumar P. Computational drug discovery of Rho-associated coiled coil kinase II (ROCK-II) inhibitors as a target for neurodegenerative disorders – an insilico docking studies. Orient. Pharm. Exp. Med. 2014. DOI 10.1007/s13596-014-0160-8.
  • Karthik D, Majumder P, Khairunnisa K, Palanisamy S, and Venugopal V. Targeting cysteine rich C1 domain of Scaffold protein Kinase Suppressor of Ras (KSR) with anthocyanidins and flavonoids - a binding affinity characterization study. Bioinformation. 2014; 10 (9): 580-585.

2015

  • Karthik D, Manojkumar P, Palanisamy S, and Sumathy A. Computational drug discovery of Rho-associated coiled coil kinase II (ROCK-II) inhibitors as a target for neurodegenerative disorders – an insilico docking studies. Orient. Pharm. Exp. Med. 2015; 15(1): 53-71.
  • Palanisamy S. Review on current trends in the management of acute STEMI. IOSR J. Pharm. Biol. Sci. 2015; 10(5): 94-101.
  • Piyush M, Cheng J, Suresh S, Palanisamy S. Comparison of relevant safety information stated on OTC medications used for cough and cold in Malaysia. J Pharma Care Health Sys. 2015; 2: 4.

2016

  • Palanisamy S, Tan Tyng Wei, Tan Wee Loon, Lim Chong Yee. Evaluation of retail pharmacists’ perception on patient safety. Asian J. Pharm. Sci. 2016; 11(1): 142-43
  • Palanisamy S, Tan Tyng Wei, Tan Wee Loon, Lim Chong Yee. Comparative study on the evaluation of patient safety in Malaysian retail pharmacy setup. Int. J. Pharmacol. Pharmaceu. Sci. 2016; 3(2): 542.
  • Sumathy A, Palanisamy S, Arathi KN, Karthik D, Srinivasan M. Microwave assisted synthesis and evaluation of some thiazole analogues as antitubercular agent. Asian Pacific J. Pharm. Phytochem. 2016; 1(01): 2-10.
  • Palanisamy S, Shim HS, Ong YC, Dayalini R, Gan SW, Hii HC, et. al. A review on current trends in the management of Ebola Virus Disease. Int. J. Pharm. Teach. Pract. 2016; 7(1): 2657-2665.
  • Palanisamy S, Marikannan M, Kingston R, Wee LT, Wei TT, Yee LC. Evaluation of patient safety culture among Malaysian retail pharmacists: results of a self-reported survey. Patient Preference and Adherence. 2016; 10: 1317-1325.
  • Palanisamy S, Arulkumaran KSG, Sumathy A. A cross sectional study on drug use evaluation of antihypertensives. J. Biomed. Res. 2016; 30(1): 13-14.
 

MS ISO/IEC 17025
TESTING
SAMM NO.650